Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
The Fed’s indication of another rate hike in 2026 is likely to keep investors cautious, particularly in rate-sensitive and foreign-portfolio-investment-driven segments. However, buying interest in select domestic sectors provided some support, the Nifty hovered above the 23,250 mark. Market participants are likely to track currency movements, US bond yields and foreign fund flows for further direction.
Pharma shares jumped after declining in the past five consecutive trading sessions.
At 13:27 IST, the barometer index, the S&P BSE Sensex jumped 51.75 points or 0.06% to 74,383.03. The Nifty 50 index added 53.65 points or 0.24% to 23,269.85.
The broader market outperformed frontline indices. The BSE 150 MidCap Index jumped 0.90% and the BSE 250 SmallCap Index rose 0.71%.
The market breadth was strong. On the BSE, 2,517 shares rose and 1,707 shares fell. A total of 235 shares were unchanged.
Trump Tariffs:
The US House of Representatives on Wednesday passed a Russia sanctions bill by 262-159 that gives President Donald Trump the power to impose tariffs of up to 100% on countries buying Russian oil and gas, directly targeting major importers such as India and China. The bill, which follows Senate approval on 7 August 2026, also expands sanctions on Russian officials, financial institutions and vessels linked to Russia's shadow fleet, while extending existing Iran sanctions by five years.
IPO Update:
National Stock Exchange of India (NSE) received bids for 2,98,19,560 shares as against 8,86,42,911 shares on offer, according to stock exchange data at 14:27 IST on 16 September 2026. The issue was subscribed 0.34 times.
The issue opened for bidding on 17 September 2026 and will close on 19 September 2026. The price band of the IPO is fixed between Rs 1,700 and 1,785 per share. An investor can bid for a minimum of 8 equity shares and multiples thereof.
Hero Motors received bids for 25,08,64,122 shares as against 8,86,07,596 shares on offer, according to stock exchange data at 14:27IST on 17 September 2026. The issue was subscribed 2.83 times.
The issue opened for bidding on 16 September 2026 and will close on 18 September 2026. The price band of the IPO is fixed between Rs 79 and 84 per share. An investor can bid for a minimum of 178 equity shares and multiples thereof.
Buzzing Index:
The Nifty Pharma index jumped 1.28% to Rs 26,480.80. The index declined 2.73% in the past five consecutive trading sessions
Alkem Laboratories (up 3.36%), Gland Pharma (up 3%), Aurobindo Pharma (up 2.88%), Dr Reddys Laboratories (up 2.81%), Laurus Labs (up 2.45%), Lupin (up 2.14%), Zydus Lifesciences (up 2%), Mankind Pharma (up 1.76%), Divis Laboratories (up 1.62%) and Biocon (up 1.54%) surged.
Numbers to Track:
The yield on India's 10-year benchmark federal paper fell 0.11% to 7.047 compared with the previous session close of 7.055.
In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 95.9200 compared with its close of 95.9100 during the previous trading session.
MCX Gold futures for 5 October 2026 settlement fell 0.64% to Rs 1,51,493.
The US Dollar Index (DXY), which tracks the greenback's value against a basket of currencies, was down 0.04% to 100.21.
The United States 10-year bond yield fell 0.32% to 4.988.
In the commodities market, Brent crude for the November 2026 settlement declined $1.40 or 1.32% to $104.43 a barrel.
Stock in Spotlight:
Semiconductor and electronics manufacturing stocks were in demand on Thursday, 17 September 2026, as SEMICON India 2026 got underway at Yashobhoomi in New Delhi. The three-day event is being held from 17 to 19 September under the theme 'Silicon to Systems: Building the Ecosystem'
Syrma SGS Technology was the top gainer, rising 7.11%. MosChip Technologies surged 4.95%, followed by Kaynes Technology India, which gained 4.71%. Dixon Technologies advanced 1.11%, while Avalon Technologies rose 1.07%.
Prime Minister Narendra Modi inaugurated SEMICON India 2026 on Thursday. The event brings together companies, policymakers, investors, researchers, startups and academic institutions from across the semiconductor and electronics value chain. The PMO said more than 600 companies and representatives from 52 countries are participating.
Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 2974.6, up 1.44% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.61% on the day, quoting at 23752.75. The Sensex is at 76008.11, down 0.66%. Gland Pharma Ltd has gained around 11.52% in last one month.
Meanwhile, Nifty Pharma index of which Gland Pharma Ltd is a constituent, has gained around 0.31% in last one month and is currently quoting at 26478.1, up 0.32% on the day. The volume in the stock stood at 6.85 lakh shares today, compared to the daily average of 9.69 lakh shares in last one month.
The PE of the stock is 34.25 based on TTM earnings ending June 26.
Gland Pharma Ltd, New India Assurance Company Ltd, Affle 3i Ltd, Titagarh Rail Systems Ltd are among the other stocks to see a surge in volumes on NSE today, 04 September 2026.
HBL Engineering Ltd saw volume of 127.24 lakh shares by 14:14 IST on NSE, a 20.33 fold spurt over two-week average daily volume of 6.26 lakh shares. The stock increased 4.20% to Rs.693.50. Volumes stood at 5.59 lakh shares in the last session.
Gland Pharma Ltd clocked volume of 26.88 lakh shares by 14:14 IST on NSE, a 9 times surge over two-week average daily volume of 2.99 lakh shares. The stock gained 1.61% to Rs.2,954.80. Volumes stood at 1.89 lakh shares in the last session.
New India Assurance Company Ltd witnessed volume of 588.98 lakh shares by 14:14 IST on NSE, a 8 times surge over two-week average daily volume of 73.61 lakh shares. The stock increased 17.69% to Rs.229.88. Volumes stood at 69.06 lakh shares in the last session.
Affle 3i Ltd clocked volume of 24.49 lakh shares by 14:14 IST on NSE, a 7.79 times surge over two-week average daily volume of 3.14 lakh shares. The stock gained 4.92% to Rs.1,593.90. Volumes stood at 13.26 lakh shares in the last session.
Titagarh Rail Systems Ltd saw volume of 27.15 lakh shares by 14:14 IST on NSE, a 7.34 fold spurt over two-week average daily volume of 3.70 lakh shares. The stock increased 2.53% to Rs.865.60. Volumes stood at 3.66 lakh shares in the last session.
Tata Technologies Ltd, Nuvoco Vistas Corporation Ltd, Medplus Health Services Ltd, HBL Engineering Ltd are among the other stocks to see a surge in volumes on BSE today, 04 September 2026.
Gland Pharma Ltd saw volume of 106.67 lakh shares by 10:46 IST on BSE, a 199.37 fold spurt over two-week average daily volume of 53501 shares. The stock dropped 0.37% to Rs.2,894.00. Volumes stood at 7489 shares in the last session.
Tata Technologies Ltd clocked volume of 21.46 lakh shares by 10:46 IST on BSE, a 23.02 times surge over two-week average daily volume of 93225 shares. The stock gained 0.62% to Rs.809.55. Volumes stood at 1.13 lakh shares in the last session.
Nuvoco Vistas Corporation Ltd notched up volume of 9.72 lakh shares by 10:46 IST on BSE, a 15.96 fold spurt over two-week average daily volume of 60914 shares. The stock rose 3.54% to Rs.349.90. Volumes stood at 33204 shares in the last session.
Medplus Health Services Ltd notched up volume of 1.84 lakh shares by 10:46 IST on BSE, a 10.24 fold spurt over two-week average daily volume of 18010 shares. The stock slipped 1.12% to Rs.655.30. Volumes stood at 1.2 lakh shares in the last session.
HBL Engineering Ltd registered volume of 7.71 lakh shares by 10:46 IST on BSE, a 9.41 fold spurt over two-week average daily volume of 81888 shares. The stock rose 6.12% to Rs.706.55. Volumes stood at 37106 shares in the last session.
Allied Blenders & Distillers Ltd, Gland Pharma Ltd, Godrej Agrovet Ltd, Graphite India Ltd are among the other stocks to see a surge in volumes on BSE today, 01 September 2026.
Vardhman Textiles Ltd saw volume of 8.68 lakh shares by 10:46 IST on BSE, a 84.7 fold spurt over two-week average daily volume of 10245 shares. The stock increased 5.98% to Rs.605.15. Volumes stood at 14610 shares in the last session.
Allied Blenders & Distillers Ltd clocked volume of 3.47 lakh shares by 10:46 IST on BSE, a 16.85 times surge over two-week average daily volume of 20566 shares. The stock gained 0.06% to Rs.618.10. Volumes stood at 9269 shares in the last session.
Gland Pharma Ltd clocked volume of 1.25 lakh shares by 10:46 IST on BSE, a 7.73 times surge over two-week average daily volume of 16181 shares. The stock gained 0.15% to Rs.2,892.50. Volumes stood at 3790 shares in the last session.
Godrej Agrovet Ltd clocked volume of 2.56 lakh shares by 10:46 IST on BSE, a 6.51 times surge over two-week average daily volume of 39338 shares. The stock gained 8.74% to Rs.669.20. Volumes stood at 11280 shares in the last session.
Graphite India Ltd witnessed volume of 3.1 lakh shares by 10:46 IST on BSE, a 5.44 times surge over two-week average daily volume of 56961 shares. The stock increased 5.14% to Rs.738.75. Volumes stood at 64011 shares in the last session.
CIE Automotive India Ltd, Zydus Lifesciences Ltd, Chennai Petroleum Corporation Ltd, Amara Raja Energy & Mobility Ltd are among the other stocks to see a surge in volumes on NSE today, 11 August 2026.
Gland Pharma Ltd clocked volume of 76.21 lakh shares by 14:14 IST on NSE, a 13.82 times surge over two-week average daily volume of 5.52 lakh shares. The stock gained 8.01% to Rs.2,881.00. Volumes stood at 7.21 lakh shares in the last session.
CIE Automotive India Ltd registered volume of 30.04 lakh shares by 14:14 IST on NSE, a 9.29 fold spurt over two-week average daily volume of 3.23 lakh shares. The stock rose 0.02% to Rs.409.60. Volumes stood at 2.36 lakh shares in the last session.
Zydus Lifesciences Ltd recorded volume of 57.93 lakh shares by 14:14 IST on NSE, a 6.23 times surge over two-week average daily volume of 9.30 lakh shares. The stock gained 4.59% to Rs.1,170.40. Volumes stood at 9.32 lakh shares in the last session.
Chennai Petroleum Corporation Ltd saw volume of 108.89 lakh shares by 14:14 IST on NSE, a 6.18 fold spurt over two-week average daily volume of 17.61 lakh shares. The stock increased 14.22% to Rs.1,416.50. Volumes stood at 7.83 lakh shares in the last session.
Amara Raja Energy & Mobility Ltd witnessed volume of 70.1 lakh shares by 14:14 IST on NSE, a 6.17 times surge over two-week average daily volume of 11.36 lakh shares. The stock increased 7.98% to Rs.969.35. Volumes stood at 15.67 lakh shares in the last session.
Market participants continued to closely monitor developments surrounding the US-Iran conflict and the progress of the monsoon. Persistent geopolitical uncertainty, along with its potential impact on crude oil prices, kept investors cautious and limited the upside in the broader market.
Investors are also expected to track domestic inflation data, movements in crude oil prices and other global geopolitical developments for further market direction. Sector- and stock-specific activity is likely to remain driven by the ongoing earnings season. The Nifty traded near the 24,600 mark.
Realty shares jumped after declining in the past two trading sessions.
At 11:25 IST, the barometer index, the S&P BSE Sensex advanced 104.44 points or 0.13% to 78,603.61. The Nifty 50 index rose 33.25 points or 0.13% to 24,604.35.
The broader market outperformed. The BSE 150 MidCap Index rose 0.31% and the BSE 250 SmallCap Index jumped 0.42%.
The market breadth was positive. On the BSE, 2,345 shares rose and 1,728 shares fell. A total of 262 shares were unchanged.
Initial Public Offer (IPO):
Dhoot Transmission received bids for 30,59,915 shares as against 2,49,56,363 shares on offer, according to stock exchange data at 11:09 IST on 10 August 2026. The issue was subscribed 0.12 times.
The issue opened for bidding on 10 August 2026 and will close on 12 August 2026. The price band of the IPO is fixed between Rs 829 and 871 per share. An investor can bid for a minimum of 17 equity shares and multiples thereof.
Molbio Diagnostics received bids for 12,09,960 shares as against 81,58,529 shares on offer, according to stock exchange data at 11:12 IST on 10 August 2026. The issue was subscribed 0.15 times.
Technocraft Ventures received bids for 2,72,32,170 shares as against 83,17,190 shares on offer, according to stock exchange data at 11:12 IST on 10 August 2026. The issue was subscribed 3.27 times.
The issue opened for bidding on 07 August 2026 and will close on 11 August 2026. The price band of the IPO is fixed between Rs 200 and 212 per share. An investor can bid for a minimum of 70 equity shares and multiples thereof.
LEAP India received bids for 3,89,18,820 shares as against 11,49,91,735 shares on offer, according to stock exchange data at 11:12 IST on 10 August 2026. The issue was subscribed 0.34 times.
The issue opened for bidding on 07 August 2026 and will close on 11 August 2026. The price band of the IPO is fixed between Rs 151 and 159 per share. An investor can bid for a minimum of 94 equity shares and multiples thereof.
The Nifty Realty index jumped 1.50% to 899.30. The index declined 0.07% in the past two trading sessions.
Brigade Enterprises (up 3.09%), DLF (up 1.43%), Godrej Properties (up 1.37%), Aditya Birla Real Estate (up 0.69%) and Lodha Developers (up 0.53%), Sobha (up 0.5%), Phoenix Mills (up 0.4%), Anant Raj (up 0.19%), Oberoi Realty (up 0.12%) advanced.
Stocks in Spotlight:
Gland Pharma added 1.60% after the company said that it has executed a strategic manufacturing and supply agreement (MSA) with one of the leading global pharmaceutical companies
Quality Power Electrical Equipments hit an upper limit of 5% after the company reported a 46.9% increase in adjusted consolidated net profit to Rs 54.5 crore in Q1 FY27 compared with Rs 37.1 crore in Q1 FY26. Total revenue rose 32.1% YoY to Rs 256.4 crore during the quarter.
Roto Pumps added 1.29% after the company reported a 46.82% rise in consolidated net profit to Rs 9.25 crore in the quarter ended 30 June 2026, compared with Rs 6.30 crore posted in the corresponding quarter last year. Revenue from operations increased 14.75% YoY to Rs 75.60 crore in the quarter ended 30 June 2026.
Global Markets:
Asian markets mostly advanced on Monday after a soft U.S. jobs report pared the risk of a near-term rise in borrowing costs, though a lack of progress in Gulf peace talks saw oil prices creep higher.
Iran said on Sunday that a deal with Oman defining new shipping lanes in the Strait of Hormuz was in its final stages but reiterated that the waterway would only reopen once the United States met other conditions.
Brent crude rises as shipping through the vital waterway remained at a trickle, while U.S. crude rose 0.79% to $78.80 a barrel.
Meanwhile, the Bank of Japan policy makers have warned of mounting inflation risks that could require a nimble, faster-than-expected pace of interest rate increases, a summary of opinions at their July meeting showed, boosting the case for a September hike.
Last week, U.S. stocks advanced on Friday, with the S&P closing at a record high to cap off a strong week of gains for the major indexes, after data showed the U.S. economy unexpectedly shed jobs last month and dampened expectations the Federal Reserve would raise interest rates at its September meeting.
The Dow Jones Industrial Average rose 151.83 points, or 0.28%, to 54,036.93, the S&P 500 gained 47.68 points, or 0.62%, to 7,757.64 and the Nasdaq Composite gained 342.26 points, or 1.30%, to 26,690.62.
The Labor Department said nonfarm payrolls decreased by 23,000 jobs last month, well below the widely reported estimate that called for an increase of 80,000 jobs. Previously reported job gains for the prior two months were also revised sharply lower, while the unemployment rate fell to 4.1% last month from 4.2% in June due to workers leaving the labor force.
Market expectations for a rate hike from the Fed at its next meeting dropped to about 44%, according to CME FedWatch down from 55% in the prior session and 67% a week ago.
Gland Pharma said that it has entered into a five-year manufacturing and supply agreement with a leading global pharmaceutical company for the technology transfer and development of 55 sterile injectable products.
The agreement covers the manufacturing and supply of oncology and non-oncology products across multiple injectable formats.
The portfolio includes products in vial, lyophilized vial, ampoule and pre-filled syringe formats, covering both conventional and complex injectables.
The agreement spans three manufacturing sites and is expected to generate annualised revenue of $90–100 million, with revenue contribution expected to commence from CY29.
The company also has scope to add more products and undertake technology-transfer activities under the partnership, which could increase the eventual revenue opportunity.
Srinivas Sadu, executive chairman, Gland Pharma, said: 'We are pleased to enter into this strategic collaboration.
The partnership highlights the confidence global pharmaceutical companies place in Gland Pharma's development, technology transfer, manufacturing, and supply capabilities.
The agreement provides meaningful long-term revenue visibility, supports expansion of our CDMO business, and creates a strong foundation for future growth.'
Gland Pharma is a Hyderabad-based pharmaceutical company focused on generic injectables and ophthalmics. It operates in more than 60 countries under a business-to-business model and offers a broad portfolio of sterile injectable products, including vials, ampoules, pre-filled syringes, lyophilized vials, infusions, oncology and ophthalmic solutions.
On a consolidated basis, Gland Pharma's net profit surged 96.57% to Rs 366.68 crore while net sales rose 22.31% to Rs 1742.79 crore in Q4 March 2026 over Q4 March 2025.